During the COVID-19 pandemic, researchers and publishers have pulled together to publish their outputs at an unprecedented rate. How will this change research culture and the way findings are disseminated in future?
On 4 May, world leaders and health organisations pledged billions for the COVID-19 response. Alex Harris explains that urgent funding gaps remain for research.
From access to tests, treatments and vaccines for everyone to coordinating urgent action – Alex Harris shares five key messages ahead of the Coronavirus Global Response Summit.
As COVID-19 continues to spread around the world, a global community of researchers are working to find out more about the virus and assess what research needs to be done to stop it.
Vaccines are one of our most powerful health tools. Here’s some of the lessons we’ve learned about the development and use of vaccines from past outbreaks.
Only when we have tools to detect, treat and prevent coronavirus disease everywhere, will we be able to stop the pandemic. Developing these tools requires new global partnerships and cooperation.
By fully funding research and development for COVID-19 testing, treatment and vaccines we can reach COVID-Zero – no preventable deaths, no further lockdowns, no more disruption.
We’ve awarded £12 million, in partnership with DFID, to speed up global COVID-19 research and development and help low- and middle-income countries prepare. But more investment is needed.
We're making our headquarters on Euston Road available as an official respite centre for local NHS staff responding to the coronavirus pandemic.